Innovative drug delivery and development Robert Davidson Chief Executive Officer of CURE. CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry-leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system, the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets.